As Semaglutide’s Popularity Soars, Rare but Serious Adverse Effects Are Emerging
Kate Ruder
Abstract
This Medical News article discusses Wegovy, Ozempic, and other GLP-1 receptor agonists used for weight management and type 2 diabetes.
Topics & Concepts
MedicineSemaglutideAdverse effectPopularityType 2 diabetesDiabetes mellitusInternal medicineIntensive care medicineEndocrinologyLiraglutideSocial psychologyPsychologyDiabetes Treatment and ManagementPharmacology and Obesity TreatmentCancer Treatment and Pharmacology